Project archive

Biomedical researchers are exploring alternative ways of obtaining such immune cells of human origin. Prof. Lachmann and his team have developed a new method laying a foundation for producing them in consistent quality and on large scale.

Brain regeneration in focus: REGENERAR develops epigenetic tools to convert cells into functional neurons for innovative therapies.

CLH report template implemented in IUCLID: Fraunhofer ITEM improves efficiency and data reuse in chemical risk assessment.

Industrial chemicals in food: the SCREENER project assesses emerging risks and evaluates potential health impacts across Europe.

PFAS in focus: benefits, risks and new assessment approaches – Fraunhofer ITEM researches health impacts and develops sustainable alternatives.

A new inhaled formulation of an anti-TSLP antibody from Novartis was tested by Fraunhofer ITEM and international partners.

Researchers at Fraunhofer ITEM have significantly developed a model of allergen provocation using allergen solutions.